DNTH
Price
$20.39
Change
-$0.85 (-4.00%)
Updated
Aug 6, 04:59 PM (EDT)
Capitalization
655.74M
IMNM
Price
$10.46
Change
-$0.39 (-3.59%)
Updated
Aug 6, 04:59 PM (EDT)
Capitalization
910.15M
7 days until earnings call
Interact to see
Advertisement

DNTH vs IMNM

Header iconDNTH vs IMNM Comparison
Open Charts DNTH vs IMNMBanner chart's image
Dianthus Therapeutics
Price$20.39
Change-$0.85 (-4.00%)
Volume$9.11K
Capitalization655.74M
Immunome
Price$10.46
Change-$0.39 (-3.59%)
Volume$5.99K
Capitalization910.15M
DNTH vs IMNM Comparison Chart in %
Loading...
DNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DNTH vs. IMNM commentary
Aug 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNTH is a Hold and IMNM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 07, 2025
Stock price -- (DNTH: $20.39 vs. IMNM: $10.46)
Brand notoriety: DNTH and IMNM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNTH: 97% vs. IMNM: 57%
Market capitalization -- DNTH: $655.74M vs. IMNM: $910.15M
DNTH [@Biotechnology] is valued at $655.74M. IMNM’s [@Biotechnology] market capitalization is $910.15M. The market cap for tickers in the [@Biotechnology] industry ranges from $210.97B to $0. The average market capitalization across the [@Biotechnology] industry is $2.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNTH’s FA Score shows that 0 FA rating(s) are green whileIMNM’s FA Score has 0 green FA rating(s).

  • DNTH’s FA Score: 0 green, 5 red.
  • IMNM’s FA Score: 0 green, 5 red.
According to our system of comparison, IMNM is a better buy in the long-term than DNTH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNTH’s TA Score shows that 5 TA indicator(s) are bullish while IMNM’s TA Score has 3 bullish TA indicator(s).

  • DNTH’s TA Score: 5 bullish, 4 bearish.
  • IMNM’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, DNTH is a better buy in the short-term than IMNM.

Price Growth

DNTH (@Biotechnology) experienced а -1.97% price change this week, while IMNM (@Biotechnology) price change was -2.70% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.54%. For the same industry, the average monthly price growth was +12.42%, and the average quarterly price growth was +13.42%.

Reported Earning Dates

DNTH is expected to report earnings on May 12, 2025.

IMNM is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Biotechnology (-0.54% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMNM($910M) has a higher market cap than DNTH($656M). IMNM YTD gains are higher at: 2.166 vs. DNTH (-2.569). DNTH has higher annual earnings (EBITDA): -116.76M vs. IMNM (-175.18M). IMNM has more cash in the bank: 317M vs. DNTH (263M). DNTH has less debt than IMNM: DNTH (1.4M) vs IMNM (4.77M). IMNM has higher revenues than DNTH: IMNM (10.9M) vs DNTH (6.52M).
DNTHIMNMDNTH / IMNM
Capitalization656M910M72%
EBITDA-116.76M-175.18M67%
Gain YTD-2.5692.166-119%
P/E Ratio3.24N/A-
Revenue6.52M10.9M60%
Total Cash263M317M83%
Total Debt1.4M4.77M29%
FUNDAMENTALS RATINGS
DNTH: Fundamental Ratings
DNTH
OUTLOOK RATING
1..100
74
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
PROFIT vs RISK RATING
1..100
53
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
53
P/E GROWTH RATING
1..100
69
SEASONALITY SCORE
1..100
22

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DNTHIMNM
RSI
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 20 days ago
79%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 6 days ago
88%
Bearish Trend 9 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
DNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FVCSX33.08N/A
N/A
Fidelity Advisor Value Strategies C
FDFIX27.03N/A
N/A
Fidelity Flex 500 Index
RYHIX121.66N/A
N/A
Rydex Health Care Inv
WHGLX13.97N/A
N/A
Westwood Quality Value Fund Inst
KTRAX9.23N/A
N/A
DWS Global Income Builder A

DNTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNTH has been loosely correlated with IMNM. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if DNTH jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNTH
1D Price
Change %
DNTH100%
-1.21%
IMNM - DNTH
54%
Loosely correlated
-0.91%
XNCR - DNTH
51%
Loosely correlated
N/A
ERAS - DNTH
48%
Loosely correlated
+7.14%
CRNX - DNTH
48%
Loosely correlated
+3.61%
SYRE - DNTH
48%
Loosely correlated
+4.39%
More

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with IDYA. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
-0.91%
IDYA - IMNM
61%
Loosely correlated
-3.52%
RXRX - IMNM
55%
Loosely correlated
-4.66%
ARWR - IMNM
54%
Loosely correlated
+0.03%
SYRE - IMNM
54%
Loosely correlated
+4.39%
DNTH - IMNM
53%
Loosely correlated
-1.21%
More